Menu

Visualizing Apoptosis as it Happens

Apoptosis is a highly regulated and critical homeostatic process in multicellular organisms, with aberrations implicated in several pathological conditions, including cancer. Download this eBook to find out more about the intrinsic and extrinsic apoptosis pathways, the biochemical and morphological stages of apoptosis, and nuclear events during apoptosis!

Apr 27, 2018
The Scientist Creative Services Team

Apoptosis is a highly regulated and critical homeostatic process in multicellular organisms. Aberrations in this form of programmed cell death have been implicated in several pathological conditions including cancer, muscular atrophy, and autoimmune disease. The biochemical and morphological events underlying apoptosis include perturbations in mitochondrial membrane potential, death receptors on the cell surface, recruitment of adapter proteins, caspase activation, and condensation of chromatin along with nuclear fragmentation. These remarkable cellular events are discussed along with a wide range of assays useful in detecting early or late events.

Download this eBook from The Scientist to find out more about:
  • The intrinsic and extrinsic apoptosis pathways
  • The biochemical and morphological stages of apoptosis
  • Apoptosis signs and signals
  • Nuclear events during apoptosis

This free eBook was made possible by an educational grant from Biotium.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.